Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07077746 · ClinicalTrials.gov registry record · Phase 2

HB-adMSCs for the Treatment of Crohn's Disease

A Phase 2 study of Crohn Disease (CD), sponsored by Hope Biosciences Research Foundation.

Recruiting
Registry status
Phase 2
Development phase
46
Enrollment target
1
Study location

NCT07077746 is a Phase 2 study of Crohn Disease (CD) that is actively recruiting participants, run by Hope Biosciences Research Foundation. The registered enrollment target is 46 participants, below the 84-participant average among 5 other Crohn Disease (CD) trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07077746, a Phase 2 study of Crohn Disease (CD), is actively recruiting participants, sponsored by Hope Biosciences Research Foundation.

RECRUITING
Registry status
Phase 2
Development phase
46 participants
Enrollment target
1
Study location

Study Summary

Methodology: Randomized, double-blind, efficacy and safety study of allogeneic HB-adMSCs vs placebo for the treatment of Crohn's Disease with a 16-week treatment period and a safety and efficacy follow up period for 52 weeks post first treatment. Treatment Duration: 16 weeks General Objectives: To assess the efficacy and safety of multiple intravenous infusions of allogeneic HB-adMSCs by improving signs and symptoms of Crohn's Disease in this subject population. Number of Subjects: 46 (23 in each treatment arm) Indication: Crohn's Disease

Conditions Studied

Crohn Disease (CD)

Interventions

  • DRUG HB-adMSCs - Hope Biosciences Adipose Derived Mesenchymal Stem Cells
  • DRUG 0.9% sodium chloride

Study Locations (1)

Texas

  • Hope Biosciences Research Foundation - Sugar Land

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2026-03
Est. Completion 2027-12
Phase Phase 2

Sponsor

Hope Biosciences Research Foundation

9 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07077746

The ClinicalTrials.gov registry entry for NCT07077746 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 84-participant average among 5 other Crohn Disease (CD) trials with a reported enrollment target (45% lower). The listed sponsor is Hope Biosciences Research Foundation, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Crohn Disease (CD) appearing as the primary indexed condition, and to 2 interventions - of which HB-adMSCs - Hope Biosciences Adipose Derived Mesenchymal Stem Cells is the first listed.

NCT07077746 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT07077746 about?

NCT07077746 is a clinical study titled "HB-adMSCs for the Treatment of Crohn's Disease". Methodology: Randomized, double-blind, efficacy and safety study of allogeneic HB-adMSCs vs placebo for the treatment of Crohn's Disease with a 16-week treatment period and a safety and efficacy follow up period for 52 weeks post first treatment. Treatment Duration: 16 weeks General Objectives: To...

What is the current status of trial NCT07077746?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 46 participants. The study started on 2026-03. Estimated completion is 2027-12.

What conditions does trial NCT07077746 study?

This clinical trial studies the following conditions: Crohn Disease (CD).

What interventions are being tested in trial NCT07077746?

The interventions under investigation include: HB-adMSCs - Hope Biosciences Adipose Derived Mesenchymal Stem Cells (DRUG), 0.9% sodium chloride (DRUG).

Who is sponsoring clinical trial NCT07077746?

This trial is sponsored by Hope Biosciences Research Foundation, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07077746 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Crohn Disease (CD)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Crohn Disease (CD)

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.